Health Condition 1: M059- Rheumatoid arthritis with rheumatoid factor, unspecified
Conditions
Interventions
Intervention1: CHITTHIRA MOOLATHI PODI
(oral administration): Should be administrated orally twice a day after food along with hot water for 45 days dosage: 2 gm
Control Intervention1: NIL: NIL
Sponsors
Dr V Nantha prasath
Eligibility
Inclusion criteria
Inclusion criteria: RA factor positive Anti ccp test positive CRP positive ANA test in few selected cases
Exclusion criteria
Exclusion criteria: Other joint diseases like osteoarthritis,seri negative spondylo arthritis,ankylosing spondylitis Infectious joint diseases like Tuberculosis, chronic poly arthritis in chickengunia viral infection Metabolic joint disease like gout Pregnancy and lactating mother Chronic renal and liver disease patients People with RA factor negative
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| In during treatment or after treatment reduction the following symptoms Pains in the more then 5 joints Morning stiffness Interphalangeal joints pain RA factor range Crp range Timepoint: 45 days | — |
Secondary
| Measure | Time frame |
|---|---|
| To evaluate the biochemical physico-chemical and phytochemical analysis of clinical trial drug To evaluate the antimicrobial activity of trial drug To evaluate the safety profile for acute and sub acute toxicity of the trial drug chitthira moolathi podi To evaluate pharmacological analysis of the clinical trial drug To evaluate Siddha parameters and modern parameters during the treatment of Uthiravatha suronitham with trial drug To evaluate the statistical analysis of the clinical trial drug Chitthira moolathi podi To evaluate the powder microscopic study and HTPLC of the trial drugTimepoint: 45 days | — |
Countries
India
Contacts
Public ContactDr A Manoharan MD s Ph D
Government siddha medical college and hospital
Outcome results
None listed